Profile
| Metric | Value |
|---|---|
| Full Name | Olema Pharmaceuticals, Inc. |
| Ticker | NASDAQ: OLMA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | olema.com |
| Employees | 101 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $27.07 | |
| Price, 1D Change | +8.11% | |
| Market Cap | $2B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.23 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$2.20 | |
| EPS, 1Y Change | -3.18% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$2.20 | |
| EPS Estimate | -$1.93 | |
| EPS Est. Change | +12.41% | |
| Revenue | $0.00 | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $27.07 | |
| Price Target | - | $44.00 |
| Price Tgt. Change | - | +62.54% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.12 | -$2.14 | -0.76% | |
| -$1.36 | -$2.20 | -61.82% | |
| -$1.93 | N/A | +12.41% | |
| -$2.33 | N/A | -5.68% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $2.81M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +416.60% | |
| Price, 3Y | +849.82% | |
| Market Cap, 1Y | +377.31% | |
| Market Cap, 3Y | +1,518.75% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | -3.18% | |
| EPS, 3Y | -22.53% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $27.07 | |
| SMA 200 | $9.63 | |
| SMA 200 vs Price | -64.41% | |
| SMA 50 | $21.27 | |
| SMA 50 vs Price | -21.43% | |
| Beta | 0.23 | |
| ATR | $2.03 | |
| 14-Day RSI | 54.89 | |
| 10-Day Volatility | 52.93% | |
| 1-Year Volatility | 161.29% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$2.20 | |
| Gross Profit | -$393.00K | |
| - | ||
| Operating Profit | -$142.26M | |
| - | ||
| Net Income | -$129.47M | |
| - | ||
| EBITDA | -$141.87M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.00 | |
| 10.50 | ||
| 10.50 | ||
| - | ||
| - | ||
| 25.46 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 6.04 | ||
| -9.30 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $408.96M | |
| $139.48M | ||
| $556.07M | ||
| $438.47M | ||
| $42.02M | ||
| $41.76M | ||
| Total Debt | $1.43M | |
| $1.17M | ||
| $4.46M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $142.26M | ||
| $142.26M | ||
| $393.00K | ||
| $17.74M | ||
| $393.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$104.35M | ||
| -$93.53M | ||
| $268.82M | ||
| Capex | $159.00K | |
| -$104.51M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citigroup | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| Goldman Sachs | → | |
| Goldman Sachs | → | |
| Oppenheimer | → | |
| JP Morgan | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Guggenheim |
Analyst sentiment
Institutional ownership
Screeners with OLMA
Data Sources & References
- OLMA Official Website olema.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1750284/000119312525273236/0001193125-25-273236-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1750284/000095017025041204/0000950170-25-041204-index.htm
- OLMA Profile on Yahoo Finance finance.yahoo.com/quote/OLMA
- OLMA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/olma
FAQ
What is the ticker symbol for Olema Pharmaceuticals, Inc.?
The ticker symbol for Olema Pharmaceuticals, Inc. is NASDAQ:OLMA
Does Olema Pharmaceuticals, Inc. pay dividends?
No, Olema Pharmaceuticals, Inc. does not pay dividends
What sector is Olema Pharmaceuticals, Inc. in?
Olema Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Olema Pharmaceuticals, Inc. in?
Olema Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Olema Pharmaceuticals, Inc. based in?
Olema Pharmaceuticals, Inc. is headquartered in United States
When did Olema Pharmaceuticals, Inc. go public?
Olema Pharmaceuticals, Inc. initial public offering (IPO) was on November 19, 2020
Is Olema Pharmaceuticals, Inc. in the S&P 500?
No, Olema Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Olema Pharmaceuticals, Inc. in the NASDAQ 100?
No, Olema Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Olema Pharmaceuticals, Inc. in the Dow Jones?
No, Olema Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Olema Pharmaceuticals, Inc. last earnings report?
Olema Pharmaceuticals, Inc.'s most recent earnings report was on November 10, 2025
When does Olema Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Olema Pharmaceuticals, Inc. is March 24, 2026